BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11066367)

  • 1. [Commercialization of genetic research and its impact on the communication of results].
    Cardinal G
    Health Law J; 1999; 7():35-48, 33. PubMed ID: 11066367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between academic institutions and industry in the life sciences--an industry survey.
    Blumenthal D; Causino N; Campbell E; Louis KS
    N Engl J Med; 1996 Feb; 334(6):368-73. PubMed ID: 8538709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustainability and the balancing of the health care and innovation agendas: the commercialization of genetic research.
    Caulfield T
    Sask Law Rev; 2003; 66(2):629-45. PubMed ID: 15212021
    [No Abstract]   [Full Text] [Related]  

  • 4. Private enterprise and public good: ethical issues in the funding of clinical research.
    Williams AH; Rowell M
    Ann R Coll Physicians Surg Can; 1999 Jun; 32(4):227-31. PubMed ID: 12385289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proprietary rights and the norms of science in biotechnology research.
    Eisenberg RS
    Yale Law J; 1987 Dec; 97(2):177-231. PubMed ID: 11660398
    [No Abstract]   [Full Text] [Related]  

  • 6. Gag clauses in clinical-trial agreements.
    Steinbrook R
    N Engl J Med; 2005 May; 352(21):2160-2. PubMed ID: 15917381
    [No Abstract]   [Full Text] [Related]  

  • 7. Dialogue: disclosure of conflicts of interest--edited excerpts from two seminars.
    Relman AS
    Sci Technol Human Values; 1985; 10(2):36-40. PubMed ID: 11649679
    [No Abstract]   [Full Text] [Related]  

  • 8. Researchers' views of the acceptability of restrictive provisions in clinical trial agreements with industry sponsors.
    Mello MM; Clarridge BR; Studdert DM
    Account Res; 2005; 12(3):163-91. PubMed ID: 16634168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing financial conflicts of interest in research.
    Bero LA
    J Am Coll Dent; 2005; 72(2):4-9. PubMed ID: 16353375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conflict of interest in clinical research: direct payment to the investigators for finding human subjects and health information.
    Puttagunta PS; Caulfield TA; Griener G
    Health Law Rev; 2002; 10(2):30-2. PubMed ID: 15739309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Data-sharing and data-withholding in genetics and the life sciences: results of a national survey of technology transfer officers.
    Campbell EG; Bendavid E
    J Health Care Law Policy; 2003; 6(2):241-55. PubMed ID: 15017960
    [No Abstract]   [Full Text] [Related]  

  • 12. No mistake in Berkeley's biotechnology deal.
    Hultin PG
    Nature; 2004 Oct; 431(7009):627. PubMed ID: 15470401
    [No Abstract]   [Full Text] [Related]  

  • 13. Academic-industry research relationships in genetics: a field apart.
    Blumenthal D; Causino N; Campbell EG
    Nat Genet; 1997 May; 16(1):104-8. PubMed ID: 9140405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Human Genome Project in the United States: a perspective on the commercial, ethical, legislative and health care issues.
    Mackler BF; Barach M
    J Int Bioethique; 1991; 2(3):149-57. PubMed ID: 11654898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research interactions between industry and academia: a corporate perspective.
    Citron P
    Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116
    [No Abstract]   [Full Text] [Related]  

  • 16. U.S. research universities' institutional conflict of interest policies.
    Slaughter S; Feldman MP; Thomas SL
    J Empir Res Hum Res Ethics; 2009 Sep; 4(3):3-20. PubMed ID: 19754230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do financial factors such as author page charges and industry funding impact on the nature of published research in infectious diseases?
    Liyanage SS; Raina Macintyre C
    Health Info Libr J; 2006 Sep; 23(3):214-22. PubMed ID: 16911128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actor-network theory: a tool to support ethical analysis of commercial genetic testing.
    Williams-Jones B; Graham JE
    New Genet Soc; 2003 Dec; 22(3):271-96. PubMed ID: 15115034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research on cancer diagnosis in Malaysia: current status.
    Looi LM; Zubaidah Z; Cheah PL; Cheong SK; Gudum HR; Iekhsan O; Ikram SI; Jamal R; Mak JW; Othman NH; Puteri JN; Rosline H; Sabariah AR; Seow HF; Sharifah NA;
    Malays J Pathol; 2004 Jun; 26(1):13-27. PubMed ID: 16190103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.